Gilead

News

Gilead launches phase 3 trials of coronavirus antiviral remd...

Gilead has said it has begun two phase 3 trials of its potential COVID-19 coronavirus antiviral remdesivir in adults affected by the disease, expanding ongoing research in the US and China.

News

US trials of Gilead's remdesivir begin against COVID-19 coro...

The first US trial of Gilead’s unapproved antiviral remdesivir has officially begun against the novel coronavirus disease COVID-19.

News

NICE rejects Roche's Polivy combination in advanced lymphoma

England’s NHS should not fund Roche’s Polivy (polatuzumab vedotin) in combination with rituximab and bendamustine for adults with a form of advanced lymphoma, NICE has said in first draft g

News

Gilead surges after WHO says remdesivir may combat coronavir...

Gilead’s share price has surged after health experts said its antiviral drug remdesivir is showing signs of efficacy against the deadly COVID-19 coronavirus outbreak.

News

Blood sample with respiratory coronavirus positive

Could Gilead's Sovaldi be the answer to COVID-19 coronavirus...

A Chinese research foundation has awarded $2.1m to four teams from Columbia University to identify antiviral drugs that work against the COVID-19 coronavirus – including a project investiga

News